MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,240 Cr | ₹2,681 Cr | ₹2,190 Cr | ₹1,660 Cr | ₹1,228 Cr |
What is the latest Total Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹3,240 Cr |
| Mar2024 | ₹2,681 Cr |
| Mar2023 | ₹2,190 Cr |
| Mar2022 | ₹1,660 Cr |
| Mar2021 | ₹1,228 Cr |
How is Total Liabilities of MARKSANS PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,240 Cr | 20.84 | |
| Mar2024 | ₹2,681 Cr | 22.40 | |
| Mar2023 | ₹2,190 Cr | 31.94 | |
| Mar2022 | ₹1,660 Cr | 35.19 | |
| Mar2021 | ₹1,228 Cr | - | |
Compare Total Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹8,515.6 Cr | 6.1% | 8.4% | -30.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 6.1% |
8.4% |
-30.3% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses